FDA warned 5D Full Disclosure that its colloidal silver eye drops, nasal spray and elixirs are unapproved new drugs, including for children and pets.
What happened
FDA reviewed the company’s website and Facebook page from November through December 2021 and found it took orders for seven colloidal silver, copper and gold products. The pages claimed the products treat or cure infections, cancer, arthritis and other diseases, and some were labeled for children and pets. FDA said the products are unapproved new drugs (not generally recognized as safe and effective and not FDA-approved) and that two are also unapproved new animal drugs.
What FDA found
The seven products are unapproved new drugs because they are not generally recognized as safe and effective and have no FDA-approved application.
FD&C Act sections 201(p), 505(a), 301(d); 21 U.S.C. 321(p), 355(a), 331(d)The company’s website and Facebook claims establish that the products are intended to treat or cure diseases, including infections, cancer and arthritis.
FD&C Act section 201(g)(1); 21 U.S.C. 321(g)(1)Plasma Colloidal Silver Eyedrops and Copper Healing Roller are unapproved new animal drugs because they are intended for pets and have no approved animal drug application.
FD&C Act sections 201(v), 512(a), 501(a)(5); 21 U.S.C. 321(v), 360b(a), 351(a)(5)
What FDA wants
FDA asks the company to write within 15 working days describing specific steps taken to correct the violations, how it will prevent recurrence, and copies of related documentation. If corrective actions cannot be completed in that time, the company must state why and when it will finish.
Who should pay attention
- online platforms and retailers selling colloidal silver products
- brands selling eye drops or nasal sprays with drug claims
- pet product sellers making unproven drug claims
This is a summary. Read the original letter on fda.gov.